BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014;58:214-24. [PMID: 24186906 DOI: 10.1093/cid/cit725] [Cited by in Crossref: 135] [Cited by in F6Publishing: 115] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin C, Chang C, Yeh C, Chang Y, Chen T, Liao C. Outcomes following diabetes admission in patients who had influenza vaccination: a population-based cohort study. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109930] [Reference Citation Analysis]
2 Pandey Y, Hasan R, Joshi KP, Habash FJ, Jagana R. Acute Influenza Infection Presenting with Cardiac Tamponade: A Case Report and Review of Literature. Perm J 2019;23:18-104. [PMID: 30624200 DOI: 10.7812/TPP/18-104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
3 Xue KS, Stevens-Ayers T, Campbell AP, Englund JA, Pergam SA, Boeckh M, Bloom JD. Parallel evolution of influenza across multiple spatiotemporal scales. Elife 2017;6:e26875. [PMID: 28653624 DOI: 10.7554/eLife.26875] [Cited by in Crossref: 87] [Cited by in F6Publishing: 48] [Article Influence: 17.4] [Reference Citation Analysis]
4 Stahl K, Seeliger B, Busch M, Wiesner O, Welte T, Eder M, Schäfer A, Bauersachs J, Haller H, Heim A, Hoeper MM, David S. Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic. Open Forum Infect Dis 2019;6:ofz381. [PMID: 31660345 DOI: 10.1093/ofid/ofz381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Kirley PD, Herlihy R, Yousey-Hindes K, Monroe ML, Ladisky M, Lynfield R, Baumbach J, Spina N, Bennett N, Billing L, Thomas A, Schaffner W, Price A, Garg S, Anderson EJ. Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015. J Pediatric Infect Dis Soc 2019;8:539-49. [PMID: 30358877 DOI: 10.1093/jpids/piy101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferdinands JM, Zimmerman RK, Silveira FP; HAIVEN Study Investigators. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clin Infect Dis 2021:ciaa1927. [PMID: 33388741 DOI: 10.1093/cid/ciaa1927] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Wilson D, Driller M, Johnston B, Gill N. The effectiveness of a 17-week lifestyle intervention on health behaviors among airline pilots during COVID-19. J Sport Health Sci 2021;10:333-40. [PMID: 33221534 DOI: 10.1016/j.jshs.2020.11.007] [Reference Citation Analysis]
8 Pinna G, Sanfilippo L, Bassareo PP, Fanos V, Marcialis MA. COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review. Curr Pediatr Rev 2021;17:38-44. [PMID: 33183207 DOI: 10.2174/1573396316666201112093920] [Reference Citation Analysis]
9 Masse S, Minodier L, Heuze G, Blanchon T, Capai L, Falchi A. Influenza-like illness outbreaks in nursing homes in Corsica, France, 2014-2015: epidemiological and molecular characterization. Springerplus 2016;5:1338. [PMID: 27563533 DOI: 10.1186/s40064-016-2957-z] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Lee FE, Treanor JJ. Viral Infections. Murray and Nadel's Textbook of Respiratory Medicine. Elsevier; 2016. pp. 527-556.e15. [DOI: 10.1016/b978-1-4557-3383-5.00032-4] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Morlacchi LC, Rossetti V, Gigli L, Amati F, Rosso L, Aliberti S, Nosotti M, Blasi F. COVID‐19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. Vaccine 2021;39 Suppl 1:A15-23. [PMID: 33422377 DOI: 10.1016/j.vaccine.2020.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sim JJL, Lim CC. Influenza Vaccination in Systemic Lupus Erythematosus: Efficacy, Effectiveness, Safety, Utilization, and Barriers. Am J Med 2021:S0002-9343(21)00608-2. [PMID: 34563493 DOI: 10.1016/j.amjmed.2021.08.038] [Reference Citation Analysis]
14 Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Review of Respiratory Medicine 2018;13:63-77. [DOI: 10.1080/17476348.2019.1555040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
15 Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect 2020;81:e61-6. [PMID: 32335173 DOI: 10.1016/j.jinf.2020.04.026] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 43.5] [Reference Citation Analysis]
16 Keilich SR, Bartley JM, Haynes L. Diminished immune responses with aging predispose older adults to common and uncommon influenza complications. Cell Immunol 2019;345:103992. [PMID: 31627841 DOI: 10.1016/j.cellimm.2019.103992] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
17 Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: protecting the most vulnerable. Eur Respir Rev 2021;30:200258. [PMID: 33650528 DOI: 10.1183/16000617.0258-2020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Nguyen C, Kaku S, Tutera D, Kuschner WG, Barr J. Viral Respiratory Infections of Adults in the Intensive Care Unit. J Intensive Care Med 2016;31:427-41. [PMID: 25990273 DOI: 10.1177/0885066615585944] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
19 Li J, Zhang D, Sun Z, Bai C, Zhao L. Influenza in hospitalised patients with malignancy: a propensity score matching analysis. ESMO Open 2020;5:e000968. [PMID: 33093022 DOI: 10.1136/esmoopen-2020-000968] [Reference Citation Analysis]
20 Babady NE. Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities. J Clin Microbiol 2016;54:2635-46. [PMID: 27280421 DOI: 10.1128/JCM.00604-16] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 de Medeiros KS, da Silva LAS, Macêdo LTA, Sarmento AC, Costa APF, Eleutério J Jr, Gonçalves AK. Potential impact of the COVID-19 in HIV-infected individuals: a systematic review Impact of the COVID-19 in HIV-Infected Individuals. Rev Assoc Med Bras (1992) 2021;67Suppl 1:127-56. [PMID: 34259769 DOI: 10.1590/1806-9282.67.Suppl1.20200754] [Reference Citation Analysis]
22 Soldevila-Domenech N, Tío L, Llorente-Onaindia J, Martín-García E, Nebot P, de la Torre R, Gurt A, Maldonado R, Monfort J; Covidmar Study Group. COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments. Front Pharmacol 2020;11:583260. [PMID: 33519443 DOI: 10.3389/fphar.2020.583260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dulek DE, de St Maurice A, Halasa NB. Vaccines in pediatric transplant recipients-Past, present, and future. Pediatr Transplant 2018;22:e13282. [PMID: 30207024 DOI: 10.1111/petr.13282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yen H. Current and novel antiviral strategies for influenza infection. Current Opinion in Virology 2016;18:126-34. [DOI: 10.1016/j.coviro.2016.05.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
25 Moiseev S, Avdeev S, Brovko M, Yavorovskiy A, Novikov PI, Umbetova K, Akulkina L, Tsareva N, Fomin V. Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis 2021;80:e16. [PMID: 32434823 DOI: 10.1136/annrheumdis-2020-217676] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
26 El Ramahi R, Freifeld A. Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients. J Oncol Pract 2019;15:177-84. [PMID: 30970229 DOI: 10.1200/JOP.18.00567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
27 Babady NE. Hospital-Associated Infections. Microbiol Spectr 2016;4. [PMID: 27337459 DOI: 10.1128/microbiolspec.DMIH2-0003-2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
28 Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, Smith PF, Rayner CR. A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression. Antimicrob Agents Chemother 2015;59:5388-95. [PMID: 26100715 DOI: 10.1128/AAC.00069-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
29 Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, Reed C, Uzicanin A; CDC Community Mitigation Guidelines Work Group. Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017. MMWR Recomm Rep 2017;66:1-34. [PMID: 28426646 DOI: 10.15585/mmwr.rr6601a1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 29.8] [Reference Citation Analysis]
30 Gao J, Couzens L, Burke DF, Wan H, Wilson P, Memoli MJ, Xu X, Harvey R, Wrammert J, Ahmed R, Taubenberger JK, Smith DJ, Fouchier RAM, Eichelberger MC. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies. mBio 2019;10:e00307-19. [PMID: 30967460 DOI: 10.1128/mBio.00307-19] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
31 O'Shea D, Widmer LA, Stelling J, Egli A. Changing face of vaccination in immunocompromised hosts. Curr Infect Dis Rep 2014;16:420. [PMID: 24992978 DOI: 10.1007/s11908-014-0420-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
32 Hurt AC, Hui DS, Hay A, Hayden FG. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses 2015;9:20-31. [PMID: 25399715 DOI: 10.1111/irv.12293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
33 Yen H. Resistance to Influenza Neuraminidase Inhibitors. In: Mayers DL, Sobel JD, Ouellette M, Kaye KS, Marchaim D, editors. Antimicrobial Drug Resistance. Cham: Springer International Publishing; 2017. pp. 491-501. [DOI: 10.1007/978-3-319-46718-4_32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Garnacho-Montero J, León-Moya C, Gutiérrez-Pizarraya A, Arenzana-Seisdedos A, Vidaur L, Guerrero JE, Gordón M, Martín-Loeches I, Rodriguez A; on Behalf GETGAG Study Group. Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit. J Crit Care 2018;48:172-7. [PMID: 30216935 DOI: 10.1016/j.jcrc.2018.08.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
35 Obermeier PE, Seeber LD, Alchikh M, Schweiger B, Rath BA. Incidence, Disease Severity, and Follow-Up of Influenza A/A, A/B, and B/B Virus Dual Infections in Children: A Hospital-Based Digital Surveillance Program. Viruses 2022;14:603. [DOI: 10.3390/v14030603] [Reference Citation Analysis]
36 Lobritto S, Danziger-Isakov L, Michaels MG, Mazariegos GV. Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs. Front Pediatr 2020;8:612627. [PMID: 33363069 DOI: 10.3389/fped.2020.612627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019;68:e1-e47. [PMID: 30566567 DOI: 10.1093/cid/ciy866] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 83.0] [Reference Citation Analysis]
38 Suárez-García I, Perales-Fraile I, González-García A, Muñoz-Blanco A, Manzano L, Fabregate M, Díez-Manglano J, Aizpuru EF, Fernández FA, García AG, Gómez-Huelgas R, Ramos-Rincón JM; SEMI-COVID-19 Network. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain. PLoS One 2021;16:e0255524. [PMID: 34343222 DOI: 10.1371/journal.pone.0255524] [Reference Citation Analysis]
39 Dembiński Ł, Dziekiewicz M, Banaszkiewicz A. Immune Response to Vaccination in Children and Young People With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Pediatric Gastroenterology & Nutrition 2020;71:423-32. [DOI: 10.1097/mpg.0000000000002810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
40 Zeitouni MO, Al Barrak AM, Al-Moamary MS, Alharbi NS, Idrees MM, Al Shimemeri AA, Al-Hajjaj MS. The Saudi Thoracic Society guidelines for influenza vaccinations. Ann Thorac Med. 2015;10:223-230. [PMID: 26664559 DOI: 10.4103/1817-1737.167065] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
41 Hawkinson DJ, Ison MG. Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation. Semin Nephrol 2016;36:417-27. [PMID: 27772626 DOI: 10.1016/j.semnephrol.2016.05.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
42 Rensink MJ, van Laarhoven HWM, Holleman F. Cocoon vaccination for influenza in patients with a solid tumor: a retrospective study. Support Care Cancer 2021;29:3657-66. [PMID: 33179137 DOI: 10.1007/s00520-020-05883-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 von Mollendorf C, Hellferscee O, Valley-Omar Z, Treurnicht FK, Walaza S, Martinson NA, Lebina L, Mothlaoleng K, Mahlase G, Variava E, Cohen AL, Venter M, Cohen C, Tempia S. Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014. J Infect Dis 2018;218:1228-37. [PMID: 29800425 DOI: 10.1093/infdis/jiy310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
44 Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667-668. [PMID: 32241793 DOI: 10.1136/annrheumdis-2020-217424] [Cited by in Crossref: 282] [Cited by in F6Publishing: 254] [Article Influence: 141.0] [Reference Citation Analysis]
45 Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Ann Hepatol. 2020;19:353-358. [PMID: 32425991 DOI: 10.1016/j.aohep.2020.05.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
46 Nuñez-Conde A, Marquez-Algaba E, Falcó V, Almirante B, Burgos J. Organizing pneumonia secondary to influenza infection: Two case reports and a literature review. Enferm Infecc Microbiol Clin (Engl Ed) 2020;38:123-6. [PMID: 31126691 DOI: 10.1016/j.eimc.2019.04.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Connelly JA, Chong H, Esbenshade AJ, Frame D, Failing C, Secord E, Walkovich K. Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatr Clin North Am 2021;68:1029-54. [PMID: 34538297 DOI: 10.1016/j.pcl.2021.05.007] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Hodinka RL. Respiratory RNA Viruses. Microbiol Spectr 2016;4. [PMID: 27726802 DOI: 10.1128/microbiolspec.DMIH2-0028-2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
49 Dela Cruz CS, Evans SE, Restrepo MI, Dean N, Torres A, Amara-Elori I, Awasthi S, Caler E, Cao B, Chalmers JD, Chastre J, Cohen TS, Cohen AH, Crothers K, Di YP, Egan ME, Feldman C, Gautam S, Halstead ES, Herold S, Jones BE, Luna C, Niederman MS, Mendez R, Menendez R, Mizgerd JP, Nusrat R, Ramirez J, Shindo Y, Waterer G, Yeligar SM, Wunderink RG. Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 2021;18:1087-97. [PMID: 34242148 DOI: 10.1513/AnnalsATS.202102-209ST] [Reference Citation Analysis]
50 Calabrese C. Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy. Med Clin North Am 2021;105:213-25. [PMID: 33589098 DOI: 10.1016/j.mcna.2020.09.008] [Reference Citation Analysis]
51 Guiot J, Henket M, Frix AN, Delvaux M, Denis A, Giltay L, Thys M, Gester F, Moutschen M, Corhay JL, Louis R; COVID-19 clinical investigators of the CHU de Liège. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic. Respir Investig 2020:S2212-5345(20)30124-6. [PMID: 32978099 DOI: 10.1016/j.resinv.2020.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
52 Valentin T, Kieslinger P, Stelzl E, Santner BI, Groselj-Strele A, Kessler HH, Tiran B. Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit. J Clin Virol 2019;111:29-32. [PMID: 30639844 DOI: 10.1016/j.jcv.2019.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
53 Lansbury LE, Brown CS, Nguyen-Van-Tam JS. Influenza in long-term care facilities. Influenza Other Respir Viruses 2017;11:356-66. [PMID: 28691237 DOI: 10.1111/irv.12464] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 11.4] [Reference Citation Analysis]
54 Collins LF, Anderson BD, Gray GC. A Case of Influenza A (H3N2) Complicated by Community-Acquired Pneumonia and Death in a Young Healthy Adult during the 2013-2014 Season. Front Public Health 2017;5:1. [PMID: 28229066 DOI: 10.3389/fpubh.2017.00001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Monreal E, Sainz de la Maza S, Fernández-Velasco JI, Natera-Villalba E, Rita CG, Rodríguez-Jorge F, Beltrán-Corbellini Á, Iturrieta-Zuazo I, Rodríguez de Santiago E, Espiño M, de Andrés A, Fortún J, Barbero E, Vázquez M, Fernández Lucas M, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19. J Clin Immunol 2021;41:315-23. [PMID: 33236261 DOI: 10.1007/s10875-020-00927-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
56 Samson SI, Konty K, Lee WN, Quisel T, Foschini L, Kerr D, Liska J, Mills H, Hollingsworth R, Greenberg M, Beal AC. Quantifying the Impact of Influenza Among Persons With Type 2 Diabetes Mellitus: A New Approach to Determine Medical and Physical Activity Impact. J Diabetes Sci Technol 2021;15:44-52. [PMID: 31747789 DOI: 10.1177/1932296819883340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Mhamdi Z, Fausther-Bovendo H, Uyar O, Carbonneau J, Venable MC, Abed Y, Kobinger G, Boivin G, Baz M. Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus. Microorganisms 2020;8:E1968. [PMID: 33322333 DOI: 10.3390/microorganisms8121968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother 2018;14:1311-22. [PMID: 29485353 DOI: 10.1080/21645515.2018.1445446] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
59 Chan RWY, Tao KP, Ye J, Lui KKY, Yang X, Ma C, Chan PKS. Inhibition of Influenza Virus Replication by Oseltamivir Derivatives. Pathogens 2022;11:237. [DOI: 10.3390/pathogens11020237] [Reference Citation Analysis]
60 Koc NS, Yildirim T, Saglam A, Arici M, Erdem Y. A patient with COVID-19 and anti-glomerular basement membrane disease. Nefrología (English Edition) 2021;41:471-3. [DOI: 10.1016/j.nefroe.2021.08.008] [Reference Citation Analysis]
61 Rajao DS, Vincent AL. Swine as a Model for Influenza A Virus Infection and Immunity. ILAR Journal 2015;56:44-52. [DOI: 10.1093/ilar/ilv002] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
62 Pascua PNQ, Mostafa HH, Marathe BM, Vogel P, Russell CJ, Webby RJ, Govorkova EA. Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection. Sci Rep 2017;7:7345. [PMID: 28779075 DOI: 10.1038/s41598-017-07433-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
63 Peteranderl C, Herold S, Schmoldt C. Human Influenza Virus Infections. Semin Respir Crit Care Med 2016;37:487-500. [PMID: 27486731 DOI: 10.1055/s-0036-1584801] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
64 Collins JP, Campbell AP, Openo K, Farley MM, Cummings CN, Hill M, Schaffner W, Lindegren ML, Thomas A, Billing L, Bennett N, Spina N, Bargsten M, Lynfield R, Eckel S, Ryan P, Yousey-Hindes K, Herlihy R, Kirley PD, Garg S, Anderson EJ. Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011-2015. Clin Infect Dis 2020;70:2121-30. [PMID: 31298691 DOI: 10.1093/cid/ciz638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
65 Pascua PNQ, Marathe BM, Vogel P, Webby RJ, Govorkova EA. Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model. J Antimicrob Chemother 2019;74:1333-41. [PMID: 30715325 DOI: 10.1093/jac/dky560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Roosenhoff R, van der Vries E, van der Linden A, van Amerongen G, Stittelaar KJ, Smits SL, Schutten M, Fouchier RAM. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance. PLoS One 2018;13:e0200849. [PMID: 30024940 DOI: 10.1371/journal.pone.0200849] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
67 Loulergue P, Kernéis S, Stern J, Kassis-chikani N, Derradji O, Escaut L, Launay O, Vittecoq D, Wyplosz B. Intention to vaccinate against influenza among health care workers caring for immunocompromised patients. American Journal of Infection Control 2016;44:1080-2. [DOI: 10.1016/j.ajic.2016.02.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
68 Muir L, Jaffer A, Rees-Spear C, Gopalan V, Chang FY, Fernando R, Vaitkute G, Roustan C, Rosa A, Earl C, Rajakaruna GK, Cherepanov P, Salama A, McCoy LE, Motallebzadeh R. Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection. Kidney Int Rep 2021;6:1799-809. [PMID: 33942026 DOI: 10.1016/j.ekir.2021.03.902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, Ho A, Hunter M, Ladhani S, Lawton M, MacMahon E, McSorley J, Pozniak A, Rodger A. British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. HIV Med 2016;17 Suppl 3:s2-s81. [PMID: 27568789 DOI: 10.1111/hiv.12424] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
70 Chen CJ, Stanciu AC. Simulating influenza epidemics with waning vaccine immunity. Medicine (Baltimore) 2021;100:e27169. [PMID: 34516511 DOI: 10.1097/MD.0000000000027169] [Reference Citation Analysis]
71 Odongo FC, Azevedo LS, Neto ED, Yeh-Li H, Caiaffa H, Pierrotti LC. Clinical Characteristics and Outcomes of Influenza A Infection in Kidney Transplant Recipients: A Single-Center Experience. Transplant Proc 2016;48:2315-8. [PMID: 27742287 DOI: 10.1016/j.transproceed.2016.06.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
72 Blot M, Chavanet P, Piroth L. [Influenza infection: An update for clinicians]. Rev Med Interne 2019;40:158-65. [PMID: 30638964 DOI: 10.1016/j.revmed.2018.12.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Terasawa M, Hayashi K, Lee JB, Nishiura K, Matsuda K, Hayashi T, Kawahara T. Anti-Influenza A Virus Activity of Rhamnan Sulfate from Green Algae Monostroma nitidum in Mice with Normal and Compromised Immunity. Mar Drugs 2020;18:E254. [PMID: 32414158 DOI: 10.3390/md18050254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
74 Price SA, Podczervinski S, Macleod K, Helbert L, Pergam SA. Understanding influenza vaccination rates and reasons for refusal in caregivers and household contacts of cancer patients. American Journal of Infection Control 2019;47:468-70. [DOI: 10.1016/j.ajic.2018.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
75 Calabrese C. Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy. Rheum Dis Clin North Am 2022;48:397-409. [PMID: 35400367 DOI: 10.1016/j.rdc.2022.02.001] [Reference Citation Analysis]
76 Mooij P, Mortier D, Stammes M, Fagrouch Z, Verschoor EJ, Bogers WMJM, Koopman G. Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques. J Gen Virol 2020;101:1229-41. [PMID: 32975505 DOI: 10.1099/jgv.0.001489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Perelygina L, Chen MH, Suppiah S, Adebayo A, Abernathy E, Dorsey M, Bercovitch L, Paris K, White KP, Krol A, Dhossche J, Torshin IY, Saini N, Klimczak LJ, Gordenin DA, Zharkikh A, Plotkin S, Sullivan KE, Icenogle J. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies. PLoS Pathog 2019;15:e1008080. [PMID: 31658304 DOI: 10.1371/journal.ppat.1008080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
78 Alshami A, Al Attas R, Azzam A, Mohammed A, Al-Quhaidan N. Detection of SARS-CoV-2 antibodies in pediatric kidney transplant patients. BMC Nephrol 2021;22:123. [PMID: 33827461 DOI: 10.1186/s12882-021-02325-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Baier C, Linderkamp C, Beilken A, Thol F, Heuser M, Ebadi E, Ganzenmueller T, Heim A, Bange FC. Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology. GMS Hyg Infect Control 2018;13:Doc08. [PMID: 30460173 DOI: 10.3205/dgkh000314] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 Ison MG, Portsmouth S, Yoshida Y, Shishido T, Mitchener M, Tsuchiya K, Uehara T, Hayden FG. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis 2020;20:1204-14. [PMID: 32526195 DOI: 10.1016/S1473-3099(20)30004-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 21.5] [Reference Citation Analysis]
81 Pagani L, Thomas Y, Huttner B, Sauvan V, Notaridis G, Kaiser L, Iten A, Pittet D, Harbarth S. Transmission and effect of multiple clusters of seasonal influenza in a Swiss geriatric hospital. J Am Geriatr Soc 2015;63:739-44. [PMID: 25900487 DOI: 10.1111/jgs.13339] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
82 Muscatello DJ, Amin J, MacIntyre CR, Newall AT, Rawlinson WD, Sintchenko V, Gilmour R, Thackway S. Inaccurate ascertainment of morbidity and mortality due to influenza in administrative databases: a population-based record linkage study. PLoS One 2014;9:e98446. [PMID: 24875306 DOI: 10.1371/journal.pone.0098446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
83 de St Maurice A, Halasa N. Preparing for the 2018-2019 influenza season. Pediatr Transplant 2018;22:e13272. [PMID: 30076691 DOI: 10.1111/petr.13272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y, Ji Y, Cong X, Gao Y. Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons. Virol J 2022;19:11. [PMID: 35033116 DOI: 10.1186/s12985-021-01739-1] [Reference Citation Analysis]
85 Koc NS, Yildirim T, Saglam A, Arici M, Erdem Y. A patient with COVID-19 and anti-glomerular basement membrane disease. Nefrologia 2021;41:471-3. [PMID: 33139077 DOI: 10.1016/j.nefro.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Branch-Elliman W, Savor Price C, McGeer A, Perl TM. Protecting the frontline: designing an infection prevention platform for preventing emerging respiratory viral illnesses in healthcare personnel. Infect Control Hosp Epidemiol 2015;36:336-45. [PMID: 25695176 DOI: 10.1017/ice.2014.52] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
87 Rotrosen ET, Neuzil KM. Influenza: A Global Perspective. Pediatr Clin North Am 2017;64:911-36. [PMID: 28734518 DOI: 10.1016/j.pcl.2017.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
88 Jaffe A, Schilsky ML, Deshpande R, Batra R. Liver Transplantation in the Time of COVID19: Barriers and Ethical considerations for Management and Next Steps. Hepatol Commun. 2020;. [PMID: 32838103 DOI: 10.1002/hep4.1568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
89 Carignan A, Boudhrioua C, Moreira S, Pelletier AA, Dufour K, Pépin J, Allard C, Marcoux D, Dufresne PJ. Changing Patterns of Disease Severity in Blastomyces dermatitidis Infection, Quebec, Canada. Emerg Infect Dis 2021;27:2810-7. [PMID: 34670643 DOI: 10.3201/eid2711.210552] [Reference Citation Analysis]
90 Abed Y, Fage C, Checkmahomed L, Venable M, Boivin G. Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice. Antiviral Research 2020;179:104807. [DOI: 10.1016/j.antiviral.2020.104807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Ansarin K, Taghizadieh A, Safiri S, Malek Mahdavi A, Ranjbar S, Teymouri S, Ahangari Maleki M, Khabbazi A. COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs. Ann Rheum Dis 2020:annrheumdis-2020-218737. [PMID: 32759256 DOI: 10.1136/annrheumdis-2020-218737] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
92 Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 2020;209:107512. [PMID: 32097670 DOI: 10.1016/j.pharmthera.2020.107512] [Cited by in Crossref: 160] [Cited by in F6Publishing: 142] [Article Influence: 80.0] [Reference Citation Analysis]
93 Schumacher S, Salmanton-García J, Cornely OA, Mellinghoff SC. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect. Infection 2021;49:387-99. [PMID: 33284427 DOI: 10.1007/s15010-020-01555-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
94 Myers MA, Smith AP, Lane LC, Moquin DJ, Aogo R, Woolard S, Thomas P, Vogel P, Smith AM. Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity. Elife 2021;10:e68864. [PMID: 34282728 DOI: 10.7554/eLife.68864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Harish MM, Ruhatiya RS. Influenza H1N1 infection in immunocompromised host: A concise review. Lung India 2019;36:330-6. [PMID: 31290419 DOI: 10.4103/lungindia.lungindia_464_18] [Reference Citation Analysis]
96 Maita H, Kobayashi T, Akimoto T, Matsuoka F, Osawa H, Kato H. Factors associated with children's seasonal influenza diagnosis by their guardians: a prospective observational study in Japan. J Prim Health Care 2022;14:29-36. [PMID: 35417328 DOI: 10.1071/HC21135] [Reference Citation Analysis]
97 de St Maurice A, Halasa N. Immunization and treatment updates: 2016-2017 influenza season. Pediatr Transplant 2017;21. [PMID: 28127885 DOI: 10.1111/petr.12884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
98 Ferri C, Giuggioli D, Raimondo V, L'Andolina M, Tavoni A, Cecchetti R, Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, Olivo D, Colaci M, Murdaca G, Brittelli R, Mariano GP, Spinella A, Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti R, Brusi V, Meliconi R, Fallahi P, Antonelli A; COVID-19 & ASD Italian Study Group. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol 2020;39:3195-204. [PMID: 32852623 DOI: 10.1007/s10067-020-05334-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
99 Abdullahi H, Elnahas A, Konje JC. Seasonal influenza during pregnancy. Eur J Obstet Gynecol Reprod Biol 2021;258:235-9. [PMID: 33476926 DOI: 10.1016/j.ejogrb.2021.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Monreal E, Maza S S, Gullón P, Natera-Villalba E, Chico-García JL, Beltrán-Corbellini Á, Martínez-Sanz J, García-Barragán N, Buisán J, Toledano R, Alonso-Canovas A, Pérez-Torre P, Matute-Lozano MC, López-Sendón JL, García-Ribas G, Corral Í, Fortún J, Montero-Errasquín B, Manzano L, Máiz-Carro L, Costa-Frossard L, Masjuan J; COVID-HRC Group. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study. J Med Virol 2021;93:2243-51. [PMID: 33165922 DOI: 10.1002/jmv.26656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Chen L, Han X, Li Y, Zhang C, Xing X. The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia. Ann Clin Microbiol Antimicrob 2021;20:55. [PMID: 34429126 DOI: 10.1186/s12941-021-00462-7] [Reference Citation Analysis]
102 Kash JC, Taubenberger JK. The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol 2015;185:1528-36. [PMID: 25747532 DOI: 10.1016/j.ajpath.2014.08.030] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 12.7] [Reference Citation Analysis]
103 Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Tappeiner C, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C; COVID-19 IMT Study Group. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. Br J Ophthalmol 2021;105:639-47. [PMID: 32586933 DOI: 10.1136/bjophthalmol-2020-316776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
104 Li L, Hsu SH, Wang C, Li B, Sun L, Shi J, Ren Y, Wang J, Zhang X, Liu J. Characteristics of viral pneumonia in non-HIV immunocompromised and immunocompetent patients: a retrospective cohort study. BMC Infect Dis 2021;21:767. [PMID: 34362320 DOI: 10.1186/s12879-021-06437-5] [Reference Citation Analysis]
105 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Parisi C. An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients. J Infect Dis 2021;224:372-3. [PMID: 33220053 DOI: 10.1093/infdis/jiaa720] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Cao J, Zhong N, Wang G, Wang M, Zhang B, Fu B, Wang Y, Zhang T, Zhang Y, Yang K, Chen Y, Yuan Q, Xia N. Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection. Sci Rep 2019;9:15899. [PMID: 31685871 DOI: 10.1038/s41598-019-52258-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
108 Natori Y, Shiotsuka M, Slomovic J, Hoschler K, Ferreira V, Ashton P, Rotstein C, Lilly L, Schiff J, Singer L, Humar A, Kumar D. A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients. Clin Infect Dis. 2018;66:1698-1704. [PMID: 29253089 DOI: 10.1093/cid/cix1082] [Cited by in Crossref: 77] [Cited by in F6Publishing: 54] [Article Influence: 25.7] [Reference Citation Analysis]
109 Ghazawi FM, Lim M, Dutz JP, Kirchhof MG. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration. Int J Dermatol 2020;59:1043-56. [PMID: 32621284 DOI: 10.1111/ijd.15028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
110 Banaszkiewicz A, Radzikowski A, Albrecht P. Immunisation in children and adolescents with inflammatory bowel disease. Adv Med Sci 2015;60:144-7. [PMID: 25689276 DOI: 10.1016/j.advms.2014.11.003] [Reference Citation Analysis]
111 Chan L, Alizadeh K, Alizadeh K, Fazel F, Kakish JE, Karimi N, Knapp JP, Mehrani Y, Minott JA, Morovati S, Rghei A, Stegelmeier AA, Vanderkamp S, Karimi K, Bridle BW. Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration. Vaccines (Basel) 2021;9:979. [PMID: 34579216 DOI: 10.3390/vaccines9090979] [Reference Citation Analysis]
112 Xue KS, Moncla LH, Bedford T, Bloom JD. Within-Host Evolution of Human Influenza Virus. Trends Microbiol 2018;26:781-93. [PMID: 29534854 DOI: 10.1016/j.tim.2018.02.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 13.5] [Reference Citation Analysis]
113 Paules C, Subbarao K. Influenza. Lancet 2017;390:697-708. [PMID: 28302313 DOI: 10.1016/S0140-6736(17)30129-0] [Cited by in Crossref: 307] [Cited by in F6Publishing: 160] [Article Influence: 61.4] [Reference Citation Analysis]
114 Marinelli TM, Kumar D. Influenza Virus Infection and Transplantation. Transplantation 2021;105:968-78. [PMID: 33044429 DOI: 10.1097/TP.0000000000003486] [Reference Citation Analysis]
115 Miarons M, Larrosa-García M, García-García S, Los-Arcos I, Moreso F, Berastegui C, Castells L, Pérez-Hoyos S, Varela J, Pau-Parra A, Varón-Galcera C, Parramon-Teixidó CJ, Martínez-Casanova J, Domènech L, García-Ortega P, Sánchez-Sancho P, Alonso-Martínez C, Gómez-Ganda L, Roch-Santed M, Gracia-Moya A, Del-Rio-Gutiérrez JM, Guillén-Del-Castillo A, Sans-Pola C, Antón A, Montoro B, Gorgas-Torner MQ; Vall d’Hebron COVID-19 Working Group. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Transplantation 2021;105:138-50. [PMID: 32941394 DOI: 10.1097/TP.0000000000003460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]
116 Memoli MJ, Czajkowski L, Reed S, Athota R, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Davey RT, Taubenberger JK. Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. Clin Infect Dis 2015;60:693-702. [PMID: 25416753 DOI: 10.1093/cid/ciu924] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 11.4] [Reference Citation Analysis]
117 Seth G, Sethi S, Bhattarai S, Saini G, Singh CB, Aneja R. SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis. Cancers (Basel) 2020;12:E3266. [PMID: 33167313 DOI: 10.3390/cancers12113266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Marathe BM, Asthagiri Arunkumar G, Vogel P, Pascua PNQ, Jones J, Webby RJ, Krammer F, Govorkova EA. Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus. Antimicrob Agents Chemother 2020;64:e00284-20. [PMID: 32631823 DOI: 10.1128/AAC.00284-20] [Reference Citation Analysis]
119 Papastergiou J, Folkins C, Li W, Young L. Community pharmacy rapid influenza A and B screening: A novel approach to expedite patient access to care and improve clinical outcomes. Can Pharm J (Ott) 2016;149:83-9. [PMID: 27076819 DOI: 10.1177/1715163516629157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
120 Pichon M, Picard C, Simon B, Gaymard A, Renard C, Massenavette B, Malcus C, Monneret G, Morfin-sherpa F, Valette M, Javouhey E, Millat G, Lina B, Josset L, Escuret V. Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency. Antiviral Research 2018;160:1-9. [DOI: 10.1016/j.antiviral.2018.10.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
121 D'Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020;26:832-834. [PMID: 32196933 DOI: 10.1002/lt.25756] [Cited by in Crossref: 394] [Cited by in F6Publishing: 348] [Article Influence: 197.0] [Reference Citation Analysis]
122 Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches. Am J Infect Control 2015;43:228-33. [PMID: 25728148 DOI: 10.1016/j.ajic.2014.11.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
123 Patel M, Chen J, Kim S, Garg S, Flannery B, Haddadin Z, Rankin D, Halasa N, Talbot HK, Reed C. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States. Emerg Infect Dis 2020;26:1720-30. [PMID: 32348234 DOI: 10.3201/eid2608.191493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
124 Kim HM, Lee N, Kim MS, Kang C, Chung YS. Characterization of neuraminidase inhibitor-resistant influenza virus isolates from immunocompromised patients in the Republic of Korea. Virol J 2020;17:94. [PMID: 32631440 DOI: 10.1186/s12985-020-01375-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
125 Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference. Antiviral Res. 2019;167:45-67. [PMID: 30974127 DOI: 10.1016/j.antiviral.2019.04.006] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 26.3] [Reference Citation Analysis]
126 Chen YC, Zhou JH, Tian JM, Li BH, Liu LH, Wei K. Adjuvanted-influenza vaccination in patients infected with HIV: a systematic review and meta-analysis of immunogenicity and safety. Hum Vaccin Immunother 2020;16:612-22. [PMID: 31567058 DOI: 10.1080/21645515.2019.1672492] [Reference Citation Analysis]
127 Abed Y, Boivin G. A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir. Open Forum Infect Dis 2017;4:ofx105. [PMID: 28852674 DOI: 10.1093/ofid/ofx105] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
128 Fontana L, Strasfeld L. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:523-44. [PMID: 30940462 DOI: 10.1016/j.idc.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
129 Sebastian S, Gonzalez HA, Peyrin-Biroulet L. Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease. J Crohns Colitis. 2020;14:1632-1643. [PMID: 32520312 DOI: 10.1093/ecco-jcc/jjaa120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
130 Rachow T, Lamik T, Kalkreuth J, Kurze S, Wagner K, Stier P, Hammersen FJ, Rüthrich MM, Winkelmann N, Klink A, Hilgendorf I, Hermann B, Lang S, Hochhaus A, von Lilienfeld-Toal M. Detection of community-acquired respiratory viruses in allogeneic stem-cell transplant recipients and controls-A prospective cohort study. Transpl Infect Dis 2020;22:e13415. [PMID: 32779843 DOI: 10.1111/tid.13415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]